95 related articles for article (PubMed ID: 11775265)
1. Macrophage activation of lymphoma-bearing mice by liposome-mediated intraperitoneal IL-2 and IL-6 gene therapy.
Wang Q; Cao X; Wang J; Zhang W; Tao Q; Ye T
Chin Med J (Engl); 2000 Mar; 113(3):281-5. PubMed ID: 11775265
[TBL] [Abstract][Full Text] [Related]
2. [Activation of macrophages from lymphoma-bearing mice by liposome mediated intraperitoneal IL-2 and IL-6 gene therapy].
Wang Q; Cao X; Wang J
Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):364-7. PubMed ID: 15624334
[TBL] [Abstract][Full Text] [Related]
3. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
Cao X; Wang Q; Ju DW; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of interleukin-2 gene-transfected tumor vaccine in combination with interleukin-6 gene-transfected tumor vaccine].
Cao X; Zhang W; Tao Q
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):602-5, 639. PubMed ID: 8697075
[TBL] [Abstract][Full Text] [Related]
5. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.
Yasuda K; Ogawa Y; Yamane I; Nishikawa M; Takakura Y
J Leukoc Biol; 2005 Jan; 77(1):71-9. PubMed ID: 15496451
[TBL] [Abstract][Full Text] [Related]
7. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
8. [The in vitro antitumor responses of murine peritoneal macrophages induced by adenovirus-mediated IL-4 and/or M-CSF gene therapy].
Yu Y; Cao X; Lei H
Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):493-6. PubMed ID: 9275496
[TBL] [Abstract][Full Text] [Related]
9. [The effect of IL-2 and IL-3 gene therapy in mice on immunological recovery receiving high dose chemotherapy].
Yu M; Cao X; Lou G
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):329-32. PubMed ID: 10920908
[TBL] [Abstract][Full Text] [Related]
10. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-13 neutralization modulates interleukin-13 induced suppression of reactive oxygen species production in peritoneal macrophages in a murine T-cell lymphoma.
Deepak P; Kumar S; Acharya A
Cell Immunol; 2008 Feb; 251(2):72-7. PubMed ID: 18501881
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor].
Dong LF; Mei HS; Song SX; Lu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):296-300. PubMed ID: 15862144
[TBL] [Abstract][Full Text] [Related]
13. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
[TBL] [Abstract][Full Text] [Related]
15. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues.
Takagi H; Furuya N; Kojima N
Cytokine; 2007 Dec; 40(3):241-50. PubMed ID: 18060800
[TBL] [Abstract][Full Text] [Related]
16. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
17. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin (IL)-4 cytotoxin on breast tumor growth after in vivo gene transfer of IL-4 receptor alpha chain.
Kawakami K; Kawakami M; Husain SR; Puri RK
Clin Cancer Res; 2003 May; 9(5):1826-36. PubMed ID: 12738741
[TBL] [Abstract][Full Text] [Related]
19. Local interleukin 2 therapy is most effective against cancer when injected intratumourally.
Jacobs JJ; Sparendam D; Den Otter W
Cancer Immunol Immunother; 2005 Jul; 54(7):647-54. PubMed ID: 15685449
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
